Angiotensin-converting enzyme inhibitors and receptor blockers in heart failure and chronic kidney disease – Demystifying controversies - ScienceDirect
A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan
Medications & Monitoring | Alport Syndrome Foundation
Management of Hypertension in Chronic Kidney Disease | Drugs
Frontiers | Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis
NKF KDOQI Guidelines
Effect of Enalapril on Glomerular Filtration Rate and Proteinuria in Children with Chronic Kidney Disease: A Randomized Controlled Trial
Role of renin-angiotensin system blockade in advanced CKD: to use or not to use? | Hypertension Research
Prescription of renin–angiotensin system blockers and risk of acute kidney injury: a population-based cohort study | BMJ Open
ACE Inhibitors and Protection Against Kidney Disease Progression
End stage renal disease free rates stratified by chronic kidney disease... | Download Scientific Diagram
Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population | Scientific Reports
Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease | NEJM
Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: a prospective cohort study - eClinicalMedicine
Risk-Benefit Ratio of Angiotensin Antagonists versus ACE Inhibitors in End-Stage Renal Disease | Drug Safety
Risk-Benefit Ratio of Angiotensin Antagonists versus ACE Inhibitors in End-Stage Renal Disease | Drug Safety
NKF KDOQI Guidelines
Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review - Journal of Cardiac Failure
ACE inhibitors and survival of hemodialysis patients
NKF KDOQI Guidelines
Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy | Circulation
Chronic Kidney Disease and RAAS Blockade: A New view of Renoprotection: Late onset renal failure from RAAS blockade (LORFFAB) Syndrome of rapid onset end-stage renal disease (SORO-ESRD) : Onuigbo, Macaulay, Onuigbo, Nnonyelum:
Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis - The Lancet
Overall end stage renal disease free rates for ACEi and ARB users after... | Download Scientific Diagram
Time to ESRD with ACE inhibitors | Download Table
![Renoprotective effects of ACE inhibitors and ARBs (large [n ~ or > 100]... | Download Table](https://www.researchgate.net/publication/250307686/figure/tbl1/AS:669311932854273@1536587808091/Renoprotective-effects-of-ACE-inhibitors-and-ARBs-large-n-or-100-randomized.png "Renoprotective effects of ACE inhibitors and ARBs (large [n ~ or > 100]... | Download Table")
Renoprotective effects of ACE inhibitors and ARBs (large [n ~ or > 100]... | Download Table
ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine
69 CKD: Prescribing Do's and Don'ts with @kidney_boy, Joel Topf - The Curbsiders
